ZEKE CAPITAL ADVISORS, LLC – CRISPR Therapeutics AG Transaction History
ZEKE CAPITAL ADVISORS, LLC portfolio value:
$2.26M
portfolio value
ZEKE CAPITAL ADVISORS, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 159K | $65.35 | 34.72K | |
| Q2 2022 | share | Increase | +15.32% | 4.61K shares | 220K | $60.77 | 34.72K |
| Q1 2022 | share | Increase | +25.82% | 6.18K shares | 76K | $62.77 | 30.11K |
| Q4 2021 | share | Increase | +82.29% | 10.80K shares | 344K | $78.85 | 23.93K |
| Q3 2021 | share | Decrease | -3.85% | -526 shares | -741K | $111.93 | 13.12K |
| Q2 2021 | share | Increase | 0.00% | 13.65K shares | 2.21M | $161.89 | 13.65K |